AbbVie Inc. financial data

Symbol
ABBV on NYSE
Industry
Pharmaceutical Preparations
Location
1 North Waukegan Road, North Chicago, IL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 76.3 % -16.9%
Quick Ratio 10.3 % -14.2%
Return On Equity 70.4 % +76.4%
Return On Assets 3.01 % -16.4%
Operating Margin 16.2 % -31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.77B shares -0.06%
Entity Public Float 300B USD +27.4%
Weighted Average Number of Shares Outstanding, Basic 1.77B shares +0.06%
Weighted Average Number of Shares Outstanding, Diluted 1.77B shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 56.3B USD +3.71%
Costs and Expenses 47.2B USD +13.6%
Operating Income (Loss) 9.14B USD -28.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.72B USD -40.5%
Income Tax Expense (Benefit) -570M USD -141%
Net Income (Loss) Attributable to Parent 4.28B USD -12%
Earnings Per Share, Basic 2.4 USD/shares -12.1%
Earnings Per Share, Diluted 2.4 USD/shares -12.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.52B USD -56.9%
Accounts Receivable, after Allowance for Credit Loss, Current 10.9B USD -2.12%
Inventory, Net 4.18B USD +2%
Assets, Current 25.6B USD -22.5%
Property, Plant and Equipment, Net 5.13B USD +2.91%
Operating Lease, Right-of-Use Asset 723M USD -2.82%
Intangible Assets, Net (Excluding Goodwill) 60.1B USD +8.02%
Goodwill 35B USD +8.25%
Other Assets, Noncurrent 9.14B USD +7.39%
Assets 135B USD +0.33%
Accounts Payable, Current 2.95B USD -20.1%
Employee-related Liabilities, Current 1.99B USD +10.2%
Liabilities, Current 38.7B USD +2.4%
Long-term Debt and Lease Obligation 60.3B USD +15.6%
Accrued Income Taxes, Noncurrent 1.26B USD -42.2%
Deferred Income Tax Liabilities, Net 2.58B USD +32.1%
Operating Lease, Liability, Noncurrent 697M USD -5.17%
Other Liabilities, Noncurrent 30.1B USD -6.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.93B USD +16.5%
Retained Earnings (Accumulated Deficit) -7.9B USD -690%
Stockholders' Equity Attributable to Parent 3.33B USD -67.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.36B USD -67.6%
Liabilities and Equity 135B USD +0.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.04B USD -3.65%
Net Cash Provided by (Used in) Financing Activities 10.8B USD
Net Cash Provided by (Used in) Investing Activities -9.59B USD -1821%
Common Stock, Shares Authorized 4B shares 0%
Common Stock, Shares, Issued 1.83B shares +0.47%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.25B USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.52B USD -56.9%
Deferred Tax Assets, Valuation Allowance 14.8B USD +9.98%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 20.9B USD +4.63%
Operating Lease, Liability 875M USD -2.89%
Depreciation 764M USD +1.6%
Payments to Acquire Property, Plant, and Equipment 193M USD +10.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.66B USD -2.08%
Lessee, Operating Lease, Liability, to be Paid 974M USD -3.37%
Property, Plant and Equipment, Gross 12.3B USD +5.43%
Operating Lease, Liability, Current 178M USD +7.23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 182M USD +7.69%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -389M USD -45.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 99M USD -7.48%
Lessee, Operating Lease, Liability, to be Paid, Year Three 145M USD 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 4.4B USD -23.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 118M USD +2.61%
Amortization of Intangible Assets 7.62B USD -4.08%
Deferred Tax Assets, Net of Valuation Allowance 6.04B USD -6.54%
Share-based Payment Arrangement, Expense 911M USD +22%
Interest Expense 2.81B USD +26.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%